Andere Sprachen Shanghai Junshi Biosciences Co., Ltd. OTC Markets

Aktien

A2N9PC

CNE100003FF7

SHJBF

Verzögert OTC Markets Andere Börsenplätze 14:51:46 20.03.2024			% 5 Tage	% 1. Jan.
1,86 ^USD	-9,71 %		-.--%	-13,49 %

29.04.	Shanghai Junshi Biosciences Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
25.04.	Shanghai Junshi Biosciences erhält Hongkong-Zulassung für Krebsmedikament Toripalimab	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Shanghai Junshi Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Shanghai Junshi Biosciences Receives Hong Kong Approval for Cancer Drug Toripalimab	25.04.
Shanghai Junshi Biosciences Co., Ltd. Receives Notice from the Drug Office, Department of Health, the Government of the Hong Kong Special Administration Region	24.04.
Shanghai Junshi Biosciences Co., Ltd. Announces Executive Changes	24.04.
Junshi Biosciences Gets Nod to Register Toripalimab Injection	08.04.
Shanghai Junshi Biosciences Co., Ltd. Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer	07.04.
Shanghai Junshi Biosciences Supplemental NDA for Lipid Drug Accepted by NMPA	03.04.
Shanghai Junshi Biosciences Co., Ltd. Announces the Acceptance of the Supplemental New Drug Applications for Ongericimab Injection	02.04.
Shanghai Junshi Biosciences' Loss Narrows in 2023, Misses Estimates	29.03.
Junshi Bio's 2023 Loss Widens, Misses Estimates	26.02.
Shanghai Junshi Biosciences Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23.02.
Junshi Biosciences Proposes Share Buyback	02.02.
Junshi Says NDA for Anti-Cancer Drug Accepted By Singapore's HSA	01.02.
Shanghai Junshi Biosciences Co., Ltd. Announces Acceptation of New Drug Application of Toripalimab by Singapore Health Sciences Authority	01.02.
Shanghai Junshi Biosciences to Narrow Losses	31.01.
Junshi Bio Inks 40 Million Yuan Deal With Shanghai Allink Biotherapeutics	31.01.
Shanghai Junshi Biosciences Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2023	30.01.
Shanghai Junshi Biosciences Co., Ltd. Announces Change of Chief Executive Officer	12.01.
Shanghai Junshi Biosciences Co., Ltd. Announces Change of General Manager	12.01.
Shanghai Junshi Biosciences Co., Ltd. and Topalliance Biosciences Inc Appoints Li Ning as Vice Chairman of the Third Session of the Board	12.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Shanghai Junshi Biosciences Co., Ltd. OTC Markets

Aktien

A2N9PC

CNE100003FF7

SHJBF

Andere Sprachen

Filter